Non-Hodgkin's Lymphoma

Showing 51 - 75 of 310

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • La Jolla, California
  • +7 more
Jul 29, 2021

Chronic Lymphoid Leukemia, Lymphoid Malignancies, Non-Hodgkin's Lymphoma Trial in Canada, United States (ABT-263)

Completed
  • Chronic Lymphoid Leukemia
  • +5 more
  • Los Angeles, California
  • +11 more
Jul 28, 2021

Non-Hodgkin's Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Japan (SyB L-0501, Rituximab)

Completed
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Nagoya-city, Aichi, Japan
  • +3 more
Jul 1, 2021

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Multiple Myeloma, Non-hodgkin's Lymphoma, Hodgkin's Disease Trial in Stony Brook (TG-0054)

Completed
  • Multiple Myeloma
  • +2 more
  • Stony Brook, New York
    Stony Brook University Hospital
Apr 14, 2021

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Morgantown (Busulfan, Fludarabine)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • Morgantown, West Virginia
    West Virginia University Hospitals Mary Babb Randolph Cancer Cen
Apr 6, 2021

Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor

Recruiting
  • Non-Hodgkin's Lymphoma
  • +18 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021

Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in Indianapolis (Meloxicam, Filgrastim)

Completed
  • Multiple Myeloma
  • Non-Hodgkin's Lymphoma
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Cancer Center
Feb 2, 2021

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Solid Tumors, Non-Hodgkin's Lymphoma Trial in Bordeaux (Efavirenz 600mg, Efavirenz 1200 mg, Efavirenz 1800 mg)

Completed
  • Solid Tumors
  • Non-Hodgkin's Lymphoma
  • Efavirenz 600mg
  • +3 more
  • Bordeaux, France
    Institut Bergonié
Jan 7, 2021

Leukemia, Myeloid, Chronic, AML, Leukemia, Lymphocytic, Acute Trial in Minneapolis (biological, drug, radiation)

Terminated
  • Leukemia, Myeloid, Chronic
  • +8 more
  • Stem Cell Transplant
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 31, 2020

Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

Completed
  • Single Umbilical Cord Blood Transplantation
  • +6 more
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Non-Hodgkin's Lymphoma Trial in Japan (Everolmus)

Completed
  • Non-Hodgkin's Lymphoma
  • Nagoya-city, Aichi, Japan
  • +7 more
Dec 17, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)

Terminated
  • Non-Hodgkin's Lymphoma
  • +5 more
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Dec 14, 2020

Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in Worldwide (HCD122)

Completed
  • Non-Hodgkin's Lymphoma
  • Hodgkin's Lymphoma
  • Chicago, Illinois
  • +27 more
Dec 11, 2020

Non-hodgkin's Lymphoma Trial in Shijiazhuang (biological, drug, procedure)

Recruiting
  • Non-hodgkin's Lymphoma
  • Auto CAR-T
  • +2 more
  • Shijiazhuang, Hebei, China
    Hematology Department, Hebei Medical University Fourth Hospital
Dec 7, 2020

Women Who Survived Cancer orRelated Illness Following Total Body

Completed
  • Leukemia
  • +3 more
  • Questionnaires, Laboratory tests, Abdominal MRI
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 3, 2020

Interdisciplinary Case-Control Study of Non-Hodgkin's Lymphoma

Completed
  • Non-Hodgkin's Lymphoma
    • Los Angeles, California
    • +3 more
    Nov 24, 2020

    Hodgkin's Disease, Non-Hodgkin's Lymphoma Trial in New York (Vorinostat, Niacinamide, Etoposide)

    Completed
    • Hodgkin's Disease
    • Non-Hodgkin's Lymphoma
    • New York, New York
      Center for Lymphoid Malignancies at CUMC
    Nov 5, 2020

    Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in Hangzhou (CAR-T cells, Ommaya Reservoir)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • Non-Hodgkin's Lymphoma
    • CAR-T cells
    • Ommaya Reservoir
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,College of Medicine, Zhejiang Univ
    Oct 22, 2020

    Non-Hodgkin's Lymphoma Trial in Japan (bendamustine HCl)

    Completed
    • Non-Hodgkin's Lymphoma
    • bendamustine hydrochloride
    • Kanagawa, Japan
    • +3 more
    Oct 19, 2020

    Non-Hodgkin's Lymphoma Trial in United States (fludarabine and rituximab, fludarabine, rituximab, pixantrone)

    Withdrawn
    • Non-Hodgkin's Lymphoma
    • fludarabine and rituximab
    • fludarabine, rituximab, pixantrone
    • Muscle Shoals, Alabama
    • +7 more
    Oct 2, 2020

    Non-hodgkin's Lymphoma Trial in Beijing, Yanda (CD19 CAR-T)

    Unknown status
    • Non-hodgkin's Lymphoma
    • CD19 CAR-T
    • Beijing, Yizhuang, China
    • +1 more
    Sep 25, 2020

    Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

    Completed
    • Acute Myeloid Leukemia
    • +12 more
    • filgrastim
    • +6 more
    • Minneapolis, Minnesota
    • +1 more
    Sep 9, 2020

    Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States

    Completed
    • Related Donors Donating PBSC to a Family Member
    • +7 more
    • Tampa, Florida
    • +11 more
    Sep 3, 2020